GSK positive on RSV vaccine for older adults
GSK plc has announced positive headline results from its AReSVi 006 phase III trial. AReSVi…
13/06/2022 - 3 minutes
News and Trends
Expansion into Europe for BlueRock Therapeutics
BlueRock Therapeutics LP, a clinical stage biopharmaceutical company and wholly-owned subsidiary of Bayer AG, has…
10/06/2022 - 2 minutes
Ziphius Vaccines and University of Antwerp to work on RNA-based delivery methods
Belgian biopharma firm Ziphius Vaccines is set to collaborate with the University of Antwerp to…
09/06/2022 - 3 minutes
Amaroq Therapeutics ‘hits early milestones’ in cancer treatment
New Zealand biotech company Amaroq Therapeutics said it is progressing towards clinical trials following a…
09/06/2022 - 2 minutes
New Forbion life sciences fund hits €470M
European life sciences venture capital firm Forbion, has announced the first €470M ($500M) close of…
09/06/2022 - 4 minutes
Cocuus raises funds to upscale alt-protein 3D bioprinting technology
Spanish start-up Cocuus has raised €2.5M ($2.7M) in its pre-Series A funding round. The funds…
09/06/2022 - 4 minutes
Neuroendocrine cancer under the spotlight as Ariceum Therapeutics launches
Ariceum Therapeutics, a private biotech company developing a radiopharmaceutical product for the diagnosis and systemic…
08/06/2022 - 2 minutes
The top European biotech investments in May 2022
Biotech investments in Europe jumped in May 2022 with a large initial public offering from…
08/06/2022 - 4 minutes
New COVID antibody cocktail developed
French biotech contract research organization ProteoGenix, Aseem Healthcare, and life sciences consultancy agency Trident Biopharm…
08/06/2022 - 2 minutes
Synklino raises €29.8M to trial cytomegalovirus drug
Danish biotech Synklino has completed a Series A fundraising round that netted €29.8M ($31.8M). The…
08/06/2022 - 2 minutes
United Therapeutics creates 3D printed lung scaffold
United Therapeutics Corporation said it has – in partnership with 3D Systems Corporation – produced…
08/06/2022 - 3 minutes
Cancer vaccine biotech CimCure raises €5M
Dutch biotech company CimCure, which is focusing on the development of vaccine-based cancer immunotherapy, has…
07/06/2022 - 3 minutes
